（来源：中国医药报） 转自：中国医药报 □ 王志钢 双黄连口服液主要成分为金银 花、黄 芩、连 翘，具有疏风解表、清热解毒的功效，适用于外感风热所 致的感冒，症见发热、咳嗽、咽痛。 冬季，天气寒冷，人们易受风寒刺激发生感冒。治疗感冒的中成药种类较多，每种药物的成分、适应证 和禁忌证各不相同。盲目选用治疗感冒中成药可能延误病情，增加不良反应发生风险。因此，正确选用 中成药是保障疗效与用药安全的关键。 按照人体感受风邪兼夹不同病邪或不同体质感邪来划分，感冒可分为风寒感冒、风热感冒、暑湿感冒和 体虚感冒；按照病证虚实来划分，风寒感冒、风热感冒、暑湿感冒为实证感冒，体虚感冒为虚证感冒。 除此之外，还有时行感冒，相当于西医的流行性感冒。 风寒感冒 风寒感冒一般发生于寒冷季节，通常由吹风、受凉等因素引起，症见恶寒重、发热轻、无汗、头痛、肢 体酸痛、鼻塞、流清涕、咽痒、咳嗽、痰白稀薄等，治疗应以辛温解表、宣肺散寒为主。临床常用以下 中成药治疗风寒感冒。 感冒清热颗粒主要成分为荆芥穗、薄荷、防风、柴胡、紫苏叶等，具有疏风散寒、解表清热的功效，用 于治疗风寒感冒引起的头痛发热、恶寒身痛、鼻流清涕、咳嗽咽干。患者服药后可喝些热粥 ...

此次公开的典型案例是医保支付资格管理制度落实以来，对外公开的第三批相关典型案例，主要包 括：辽宁省抚顺市博爱医院串换诊疗服务项目欺诈骗保案例、贵州省六盘水市水旷医院（现水矿医院） 虚构诊疗服务项目欺诈骗保案例、浙江省嘉兴平湖市聚隆大药房协助冒名购药骗取医保基金案例等。 新华社北京12月20日电（记者彭韵佳）国家医保局12月20日发布新一批定点医药机构相关人员欺诈 骗保典型案例。此次曝光的案例中，违法违规的定点医药机构均被予以行政处罚和协议处理，涉案相关 人员同步纳入记分管理，并被暂停一定期限内的医保支付资格。 医保支付资格管理制度是在医保协议管理的框架下，依法依规认定相关人员的责任，对责任人实 行"驾照式记分"，监管到人，维护医保基金安全。 以重庆市潼南区崇龛镇薛家村卫生室虚构医药服务项目骗取医保基金案例为例，2025年4月，重庆 市潼南区医保局联合有关部门对潼南区崇龛镇薛家村卫生室开展现场检查，发现其存在过度诊疗、患者 未领取中药材及通宣理肺丸等药品但上传医保结算、对未实施理疗项目的参保人员虚计收费骗取医保基 金等问题。当地医保局责令该机构退回基金损失，并进行相应处罚，对村卫生室医生何某记10分。随 后，根 ...

Core Viewpoint - The acceleration of traditional Chinese medicine (TCM) centralized procurement aims to address the long-standing issue of inflated prices in the TCM market, with significant price reductions observed in recent procurement rounds [1][6][9] Group 1: Price Reduction and Procurement Process - The average price reduction for selected TCM products in the third batch of centralized procurement reached 68%, with some products seeing reductions over 90% [1] - The first batch of TCM centralized procurement in 2021 resulted in an average price reduction of 42.27%, while the second batch in 2023 saw a reduction of 49.36% [3] - The third batch of procurement included 19 unique products, with an average price reduction of 47.38% [3] Group 2: Governance and Long-term Mechanisms - Experts suggest that a long-term mechanism for price governance should involve both centralized procurement and regular monitoring of listed prices to identify anomalies [1][2] - The establishment of a robust procurement credit system is essential to ensure that high-priced products are closely monitored for sales performance [2] Group 3: Challenges in the TCM Market - The high prices of TCM are attributed to various factors, including the impact of climate on raw material prices, insufficient market competition, and the complexity of pricing structures [6][7] - The presence of monopolistic practices in the TCM sector leads to concentrated pricing power, exacerbating the issue of inflated prices [7] Group 4: Regional Implementation and Impact - Various provinces, including Guangdong and Jiangsu, are actively implementing centralized procurement to ensure that selected products are available in hospitals and to manage prices effectively [4] - The expected annual savings for patients from the recent procurement efforts are estimated to exceed 31 million yuan [4] Group 5: Future Recommendations - Recommendations for future procurement processes include establishing a reasonable price increase mechanism during supply shortages and ensuring transparency in production costs [5] - A national collaborative governance framework is proposed to standardize pricing rules and monitor price fluctuations across provinces [9][10]